{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:56:25Z","timestamp":1789473385527,"version":"build-2803163510"},"reference-count":110,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R37 AI076119"],"award-info":[{"award-number":["R37 AI076119"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F31 AI155158-01A1"],"award-info":[{"award-number":["F31 AI155158-01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM008367"],"award-info":[{"award-number":["T32 GM008367"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,11,17]]},"abstract":"<jats:p>4\u2032-Ethynyl-2-fluoro-2\u2032-deoxyadenosine (EFdA, MK-8591, islatravir) is a nucleoside reverse transcriptase translocation inhibitor (NRTTI) with exceptional potency against wild-type (WT) and drug-resistant HIV-1 in phase III clinical trials. EFdA resistance is not well characterized.<\/jats:p>","DOI":"10.1128\/aac.01167-21","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T16:24:47Z","timestamp":1631550287000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":22,"title":["Development of Human Immunodeficiency Virus Type 1 Resistance to 4\u2032-Ethynyl-2-Fluoro-2\u2032-Deoxyadenosine Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor-Resistant Strains"],"prefix":"10.1128","volume":"65","author":[{"given":"Maria E.","family":"Cilento","sequence":"first","affiliation":[{"name":"Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA"},{"name":"Children\u2019s Healthcare of Atlanta, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron B.","family":"Reeve","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Michailidis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana V.","family":"Ilina","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Nagy","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mitsuya","sequence":"additional","affiliation":[{"name":"Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan"},{"name":"Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"},{"name":"Department of Clinical Sciences, Kumamoto University Hospital, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Parniak","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-4967","authenticated-orcid":true,"given":"Philip R.","family":"Tedbury","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA"},{"name":"Children\u2019s Healthcare of Atlanta, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5840-154X","authenticated-orcid":true,"given":"Stefan G.","family":"Sarafianos","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA"},{"name":"Children\u2019s Healthcare of Atlanta, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","volume-title":"Fact sheet: World AIDS Day.","author":"UNAIDS","year":"2020","unstructured":"UNAIDS. 2020. Fact sheet: World AIDS Day. UNAIDS, New York, NY."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002321"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1701568"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2007.12.015"},{"key":"e_1_3_2_6_2","volume-title":"Highly active antiretroviral therapy (HAART).","author":"Eggleton JS","year":"2020","unstructured":"Eggleton JS, Nagalli S. 2020. Highly active antiretroviral therapy (HAART). StatPearls, Treasure Island, FL."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013552"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1004180"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2016.08.031"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.4081\/idr.2013.s1.e5"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7542804"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.5.1934"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2479983"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00277-07"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.11.4189-4194.2004"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.4.875"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.12.5653"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.2217\/hiv.09.40"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200206140-00004"},{"key":"e_1_3_2_20_2","first-page":"22","article-title":"K65R, TAMs and tenofovir","volume":"6","author":"Miller MD","year":"2004","unstructured":"Miller MD. 2004. K65R, TAMs and tenofovir. AIDS Rev 6:22\u201333.","journal-title":"AIDS Rev"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000218548.77457.76"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.7.1783-1788.2000"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.2.282"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200002000-00002"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06102-4"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199814000-00004"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1201"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000169"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.03.004"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000467"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01703-13"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1170\/T900"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1021\/ol202116k"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206360200"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2008.04.007"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1605223113"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.036616"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.562694"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.562694"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.03.001"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00744-17"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2697"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx280"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-10-65"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05036-14"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00270-09"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159517"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00723-12"},{"key":"e_1_3_2_49_2","article-title":"First-in-human trial of MK-8591-eluting implants demonstrates concentrations suitable for HIV prophylaxis for at least one year","author":"Matthews RP","year":"2019","unstructured":"Matthews RP, Barrett SE, Patel M, Zhu W, Fillgrove KL, Haspeslagh L, Chen G, Levine V, Zhang S, Goodey A, Forster SP, Vargo R, Grobler JA, Stoch SA, Iwamoto M. 2019. First-in-human trial of MK-8591-eluting implants demonstrates concentrations suitable for HIV prophylaxis for at least one year. J Int AIDS Soc. https:\/\/programme.ias2019.org\/Abstract\/Abstract\/4843.","journal-title":"J Int AIDS Soc."},{"key":"e_1_3_2_50_2","article-title":"Long-acting oral and parenteral dosing of MK-8591 for HIV treatment or prophylaxis","author":"Grobler J","year":"2016","unstructured":"Grobler J, Friedman E, Barrett SE, Wood SL, Ankrom W, Fillgrove KL, Lai M-T, Gindy M, Iwamoto M, Hazuda DJ. 2016. Long-acting oral and parenteral dosing of MK-8591 for HIV treatment or prophylaxis. Top Antivir Med. https:\/\/www.croiconference.org\/abstract\/long-acting-oral-and-parenteral-dosing-mk-8591-hiv-treatment-or-prophylaxis\/.","journal-title":"Top Antivir Med."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05729-11"},{"key":"e_1_3_2_52_2","article-title":"MK-8591 concentrations at sites of HIV transmission and replication","author":"Grobler J","year":"2017","unstructured":"Grobler J, Friedman E, Barrett SE, Wood SL, Ankrom W, Fillgrove KL, Lai M-T, Gindy M, Iwamoto M, Hazuda DJ. 2017. MK-8591 concentrations at sites of HIV transmission and replication. Top Antivir Med. https:\/\/www.natap.org\/2017\/CROI\/croi_92.htm.","journal-title":"Top Antivir Med."},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01058-18"},{"key":"e_1_3_2_54_2","unstructured":"Grobler JA Fillgrove K Hazuda D Huang Q Lai MT Matthews RP Rudd DJ Vargo R. 2019. MK-8591 potency and PK provide high inhibitory quotients at low doses QD and QW. Conference on Retroviruses and Opportunistic Infections (CROI) San Francisco CA."},{"key":"e_1_3_2_55_2","article-title":"Gilead and Merck announce agreement to jointly develop and commercialize long-acting, investigational treatment combinations of lenacapavir and islatravir in HIV","author":"Kottle M","year":"2021","unstructured":"Kottle M, Ross J, Danenbaum P, McConnell I. 2021. Gilead and Merck announce agreement to jointly develop and commercialize long-acting, investigational treatment combinations of lenacapavir and islatravir in HIV. Businesswire.","journal-title":"Businesswire."},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.5.1539-1546.2001"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00083-08"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2008.04.007"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.18.10027"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.8.3355-3360.2005"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M308806200"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05578-11"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00040-15"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D302"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565100-00008"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2004.00100.x"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2013.03.014"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.0c00967"},{"key":"e_1_3_2_69_2","unstructured":"Diamond T Ngo W Xu M Goh SL Rodriguez S Lai M-T Asante-Appiah E Grobler J. 2020. Islatravir selects for HIV-1 variants in MT4-GFP cells that profoundly reduce replicative capacity in peripheral blood mononuclear Cells. HIV Glasgow 2020 Glasgow Scotland."},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2011.11.004"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20041056"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2018.07.014"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000216363.36786.2b"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg100"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.15.8548-8554.2003"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.6.1449"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1998.2208"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.153783"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr005"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.11.3038"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804660105"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02203-06"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1086\/655764"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2011.11.001"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(02)01433-X"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00723-12"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.10.2231"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.76.7.3248-3256.2002"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1994.1542"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)60646-5"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.2307\/2992081"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-36-1-59"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.18.8392"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature15399"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01726-08"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.6.1896-1905.2002"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.2144\/000112072"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.5.1652-1663.2004"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btm404"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn464"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr694"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06000-11"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M212911200"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1990.tb15306.x"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00440"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.01.081"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.07.035"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.09.054"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.01.041"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.398180"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01167-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01167-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:35:51Z","timestamp":1645468551000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01167-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":110,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,11,17]]}},"alternative-id":["10.1128\/AAC.01167-21"],"URL":"https:\/\/doi.org\/10.1128\/aac.01167-21","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.04.281485","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"2021-06-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01167-21"}}